A detailed history of High Vista Strategies LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 12,743 shares of KYMR stock, worth $520,169. This represents 0.24% of its overall portfolio holdings.

Number of Shares
12,743
Holding current value
$520,169
% of portfolio
0.24%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.16 - $52.4 $384,328 - $667,733
12,743 New
12,743 $603,000
Q1 2023

May 15, 2023

BUY
$24.84 - $38.75 $634,165 - $989,287
25,530 New
25,530 $756,000
Q3 2021

Nov 15, 2021

SELL
$47.8 - $66.66 $888,458 - $1.24 Million
-18,587 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$31.08 - $51.95 $144,397 - $241,359
4,646 Added 33.33%
18,587 $901,000
Q1 2021

May 17, 2021

SELL
$35.64 - $85.46 $113,192 - $271,420
-3,176 Reduced 18.55%
13,941 $542,000
Q4 2020

Feb 16, 2021

BUY
$28.07 - $87.83 $480,474 - $1.5 Million
17,117 New
17,117 $1.06 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.23B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.